VTN and Alzheimer disease: A1-type astrocytes that are up-regulated in AD patients have been reported to secrete exosomes with high levels of complement proteins (CPs), which may contribute to neuronal injury in the late inflammatory phase of AD (Goetzl et al., 2018b).